Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 100Breast Neoplasms 74Fallopian Tube Neoplasms 47Multiple Myeloma 32Carcinoma, Ovarian Epithelial 27Neoplasms 23Lymphoma 15Triple Negative Breast Neoplasms 12Sarcoma 12Recurrence 12Neoplasm Metastasis 12Lymphoma, Large B-Cell, Diffuse 10Lymphoma, Non-Hodgkin 8Hodgkin Disease 8Neoplasms, Plasma Cell 6Prostatic Neoplasms 5Burkitt Lymphoma 5Solid Tumors 4Sarcoma, Kaposi 4Sarcoma, Ewing 4Pancreatic Neoplasms 4Lymphoma, T-Cell, Peripheral 4Lymphoma, Mantle-Cell 4Leiomyosarcoma 4Endometrial Neoplasms 4Carcinoma 4Breast Neoplasms, Male 4Uterine Cervical Neoplasms 3Rhabdomyosarcoma 3Peritoneal Neoplasms 3

Interventions

Pyridoxine 3Celecoxib 2Capecitabine 2tegafur-gimeracil-oteracil 1mecobalamin 1liposomal doxorubicin 1Vitamin B 6 1Urea 1Tobacco Use Cessation Devices 1Standard of Care 1S 1 (combination) 1Radiotherapy 1Low-Level Light Therapy 1Diclofenac 1Brimonidine Tartrate 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hand-Foot Syndrome × liposomal doxorubicin × Clear all
NCT00248248 2011-10-12

DOXIL for Consolidation Therapy in Ovarian Cancer.

Southeastern Gynecologic Oncology

Phase 2 Completed
45 enrolled
Gynecologic

Ovarian Neoplasms, Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡